̽��ֱ��

Cambridge researchers are taking part in the world’s first clinical trial of red blood cells that have been grown in a laboratory for transfusion into another person.

Researchers have been able to alter the blood type of deceased donor kidneys using “molecular scissors”.

A new method of analysing cancer patients’ blood for evidence of the disease could be up to ten times more sensitive than previous methods according to new research led by the ̽��ֱ�� of Cambridge.

An international team of researchers led by scientists at the ̽��ֱ�� of Cambridge and MSD has created the first detailed genetic map of human proteins, the key building blocks of biology. These discoveries promise to enhance our understanding of a wide range of diseases and aid development of new drugs.

A explores understandings of a vital bodily fluid in the period 1400-1700. Its contributors offer insight into both theory and practice during a period that saw the start of empiricism and an overturning of the folklore that governed early medicine.

Cambridge researchers have played a leading role in several studies released today looking at how variation in and potentially heritable changes to our DNA, known as epigenetic modifications, affect blood and immune cells, and how this can lead to disease. 

A new treatment that might one day help all patients with haemophilia, including those that become resistant to existing therapies, has been developed by researchers at the ̽��ֱ�� of Cambridge.

In the first genome-scale experiment of its kind, researchers have gained new insights into how a mouse embryo first begins to transform from a ball of unfocussed cells into a small, structured entity. Published in Nature, the single-cell genomics study was led by the European Bioinformatics Institute (EMBL-EBI) and the ̽��ֱ�� of Cambridge.

A technique for reducing the number of infectious malaria parasites in whole blood could significantly reduce the number of cases of transmission of malaria through blood transfusion, according to a collaboration between researchers in Cambridge, UK, and Kumasi, Ghana.

Scientists at the Cambridge Institute for Medical Research at the ̽��ֱ�� of Cambridge and the Medical Research Council Laboratory of Molecular Biology have taken advantage of revolutionary developments in microscopic imaging to reveal the origins of leukaemia.